ROOTED IN SCIENTIFIC INNOVATION. INSPIRED BY RESULTS.
MSPR's solutions give our sponsors efficiency and our investigators the time and freedom to concentrate on high-level in-clinic procedures.
OUR STORY
MedSpa Partners Research is the first consortium for cosmetic medicine research in North America. Founded in 2020 and led by Dr. Shannon Humphrey, MedSpa Partners’ Chief Research Officer and prominent Dermatologist and Clinical Researcher, MSPR is a network of some of North America’s most experienced and renowned cosmetic research centres. MSPR’s goal is to conduct the highest quality cosmetic clinical research while maintaining an unwavering commitment to GCP in parallel with increasing productivity, efficiency, and consistency.
UNPARALLELLED STANDARDS
MSPR’s team of highly qualified and experienced researchers, scientists, physicians, and technicians is constantly exploring new techniques, materials, and treatments to improve the safety, efficacy, and overall results of cosmetic procedures. Our investigators have been involved in groundbreaking discoveries and advances in the field, resulting in significant benefits for sponsors, fellow practitioners, and patients.
A SINGLE POINT OF CONTACT GIVING YOU ACCESS TO INDUSTRY-FIRST BENEFITS
Geographic & demographic diversification
Unparalleled Research Investigators & Coordinators
Centralized & standardized processes
Internal training network & quality control
Expert Budget & Contract Specialists
Innovative marketing solutions for subject screening & recruitment
MedSpa Partners Research (MSPR) is the first cosmetic medicine research consortium in North America. Founded in 2020 and led by Dr. Shannon Humphrey, MSPR stands out for its unparalleled research experience, diversification, and streamlined study administration. We are committed to good clinical practice, innovation, safety, and network collaboration, ultimately ensuring the highest quality in cosmetic clinical research.
OUR CURATED CLINICAL APPROACH
1
STRATEGIC PLANNING*
Protocol Consultation Scale Development
2
PROTOCOL DEV & APPROVAL*
Study Design Advisory Panel
3
SITE SELECTION & INITIATION*
Feasibility & Multi Site Start Up Regulatory & IRB Submission
4
FIRST PATIENT, FIRST VISIT
FPFV capabilities High Enrollment capabilities
5
LAST PATIENT, LAST VISIT
Expedited Last Subject Closeout & Archiving Advisory Panel & Results
